Lilia-Celine Lozada
Stock Analyst at JP Morgan
(1.54)
# 3,528
Out of 5,240 analysts
10
Total ratings
40%
Success rate
2.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Neutral | $26 → $29 | $23.92 | +21.24% | 3 | May 7, 2026 | |
| ATRC AtriCure | Maintains: Overweight | $42 → $48 | $26.59 | +80.52% | 4 | Dec 16, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $14 → $12 | $10.44 | +14.94% | 1 | Nov 7, 2025 | |
| TMCI Treace Medical Concepts | Downgrades: Underweight | $8 → $5 | $2.54 | +97.24% | 2 | Nov 7, 2025 |
Envista Holdings
May 7, 2026
Maintains: Neutral
Price Target: $26 → $29
Current: $23.92
Upside: +21.24%
AtriCure
Dec 16, 2025
Maintains: Overweight
Price Target: $42 → $48
Current: $26.59
Upside: +80.52%
DENTSPLY SIRONA
Nov 7, 2025
Maintains: Neutral
Price Target: $14 → $12
Current: $10.44
Upside: +14.94%
Treace Medical Concepts
Nov 7, 2025
Downgrades: Underweight
Price Target: $8 → $5
Current: $2.54
Upside: +97.24%